Literature DB >> 31491656

Cognitive behavioral therapy for insomnia: A meta-analysis of long-term effects in controlled studies.

Tanja van der Zweerde1, Lampros Bisdounis2, Simon D Kyle3, Jaap Lancee4, Annemieke van Straten5.   

Abstract

Cognitive behavioral therapy for insomnia (CBT-I) is a treatment with moderate to large effects. These effects are believed to be sustained long-term, but no systematic meta-analyses of recent evidence exist. In this present meta-analysis, we investigate long-term effects in 30 randomized controlled trials (RCTs) comparing CBT-I to non-active control groups. The primary analyses (n = 29 after excluding one study which was an outlier) showed that CBT-I is effective at 3-, 6- and 12-mo compared to non-active controls: Hedges g for Insomnia severity index: 0.64 (3 m), 0.40 (6 m) and 0.25 (12 m); sleep onset latency: 0.38 (3 m), 0.29 (6 m) and 0.40 (12 m); sleep efficiency: 0.51 (3 m), 0.32 (6 m) and 0.35 (12 m). We demonstrate that although effects decline over time, CBT-I produces clinically significant effects that last up to a year after therapy.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Behavior therapy; Cognitive behavior therapy; Cognitive therapy; Insomnia; Long-term; Randomized clinical trial; Sleep initiation or maintenance disorder

Mesh:

Year:  2019        PMID: 31491656     DOI: 10.1016/j.smrv.2019.08.002

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  31 in total

1.  Follow-Up Analyses From a Wait-List Controlled Trial of Occupational Therapist-Delivered Cognitive-Behavioral Therapy for Insomnia Among Veterans With Chronic Insomnia.

Authors:  Aaron M Eakman; Arlene A Schmid; Natalie R Rolle; Adam R Kinney; Kimberly L Henry
Journal:  Am J Occup Ther       Date:  2022-03-01

2.  Using Alcohol and Cannabis as Sleep Aids: Associations with Descriptive Norms Among College Students.

Authors:  Scott Graupensperger; Brittney A Hultgren; Anne M Fairlie; Christine M Lee; Mary E Larimer
Journal:  Behav Sleep Med       Date:  2022-02-12       Impact factor: 3.492

3.  Patience required: increasing sleep duration in the months to years following CBT-I.

Authors:  Adam D Bramoweth
Journal:  J Clin Sleep Med       Date:  2022-07-01       Impact factor: 4.324

4.  Cannabinoids in the Treatment of Insomnia Disorder: A Systematic Review and Meta-Analysis.

Authors:  Chiranth Bhagavan; Stacey Kung; Marjan Doppen; Mary John; Iva Vakalalabure; Karen Oldfield; Irene Braithwaite; Giles Newton-Howes
Journal:  CNS Drugs       Date:  2020-11-26       Impact factor: 5.749

5.  Insomnia in Older Adults.

Authors:  Vivian Nguyen; Tessy George; Glenna S Brewster
Journal:  Curr Geriatr Rep       Date:  2019-10-22

6.  Why Treat Insomnia?

Authors:  Michael L Perlis; Wilfred R Pigeon; Michael A Grandner; Todd M Bishop; Dieter Riemann; Jason G Ellis; Joseph R Teel; Donn A Posner
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec

7.  Treatment of chronic primary sleep onset insomnia with Kundalini yoga: a randomized controlled trial with active sleep hygiene comparison.

Authors:  Sat Bir S Khalsa; Michael R Goldstein
Journal:  J Clin Sleep Med       Date:  2021-09-01       Impact factor: 4.324

8.  The case for investigating a bidirectional association between insomnia symptoms and eating disorder pathology.

Authors:  Kara A Christensen; Nicole A Short
Journal:  Int J Eat Disord       Date:  2021-03-04       Impact factor: 5.791

Review 9.  Efficacy of cognitive behavioral therapy for insomnia in breast cancer: A meta-analysis.

Authors:  Yan Ma; Daniel L Hall; Long H Ngo; Qingqing Liu; Paul A Bain; Gloria Y Yeh
Journal:  Sleep Med Rev       Date:  2020-09-07       Impact factor: 11.609

10.  The effect of acceptance and commitment therapy on insomnia and sleep quality: A systematic review.

Authors:  Nader Salari; Habibolah Khazaie; Amin Hosseinian-Far; Behnam Khaledi-Paveh; Hooman Ghasemi; Masoud Mohammadi; Shamarina Shohaimi
Journal:  BMC Neurol       Date:  2020-08-13       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.